receive a diagnosis for a life-altering condition. Today, with the recognition that a healthy lifestyle includes nutritious food choices, exercise, movement, and positive social connections, providers can share that advice at each patient visit. This message should be as powerful as the messages received by the public on a regular basis promoting the power of medications in response to illness, symptoms, and the inconvenience of not feeling well.
WORKS CITED https://qr2.mobi/Polypharm-ws
Self-Assessment Answers and Rationales
1. The correct answer is 1. Rationale: Patients suffering from multimorbidity often have impaired mental health, with the potential for two to three times higher rates of depression. 2. The correct answer is 2. Rationale: There are some treatment plans in which polypharmacy is necessary. Those situations should be regularly monitored, preferably with the consultation of a
clinical pharmacist to avoid redundancy in medication and overlooked potential for counterindication. 3. The correct answer is 3. Rationale: Medications can trigger adverse reactions and events because of reactions from the body and/or how the drug interacts with the body.
POLYPHARMACY: IMPACT AND EFFECTS Final Examination Questions
Select the best answer for each question and mark your answers on page 76. For faster service, complete your test online at EliteLearning.com/Book
48. Which of the following chronic diseases is NOT one of those with the highest rates of hyperpolypharmacy? a. Diabetes mellitus. b. Hypertension. c. Chronic kidney disease. d. Glaucoma. 49. Guidelines pertaining to medication deprescription should include: a. Identification of medications that have a greater risk versus benefit. b. Analysis of dose and frequency. c. Methods to identify patients receptive to deprescribing. d. All of the choices. 50. Pharmacokinetics is the study of: a. The absorption, distribution, metabolism, and excretion of medications. b. The risk versus benefit ratio for a specific medication. c. The medication outcomes based on disease protocol. d. The increase and decrease of effectiveness of pharmaceuticals post manufacture and distribution. 51. Pharmacodynamics is the study of: a. The absorption, distribution, metabolism, and excretion of medications. b. The impact of medication on the body, including bodily responses based on drug interactions. c. Declining changes in cell extrapolation. d. Dynamic interactions of physiology and systems. 52. The overall impact of too many prescriptions can result in a:
43. Multimorbidity occurs when:
a. A person is born with multiple congenital challenges. b. A person is diagnosed with two or more chronic health conditions. c. A person is symptomatic of multiple health issues. d. A person has multiple symptoms from one disease. 44. Physical ability impairment as a result of multimorbidity can have the following results: a. Sense of weakness and fall risk. b. Increased strength and improved gait. c. Impaired capacity and improved strength. d. Decreased intuition and improved self care. 45. In addition to the six aspects of life with chronic conditions that have been identified by Bissenbaker et al. (2023), research also showed: a. Infirmities. b. Congenital defects. c. Health inequities. d. Health equity. 46. Which statement is true about polypharmacy? a. There is not one global definition of polypharmacy. b. There is a definition of polypharmacy that sets global standards. c. Polypharmacy has 15 definitions. d. Polypharmacy is when a person takes three or four medications daily. 47. What is the actual prevalence of polypharmacy in adults? a. 50% b. Between 10% and 90% c. Approximately 65% d. 15%
a. Drug-drug interaction. b. Mandatory overdose. c. Prescription cascade. d. Multimorbidity.
EliteLearning.com/Massage-Therapy
Book Code: MTX1326
Page 60
Powered by FlippingBook